Eloxx Pharmaceuticals, Inc. (ELOX)
14.14
-1.70
(-10.73%)
USD |
OTCM |
Sep 03, 12:49
Eloxx Pharmaceuticals Research and Development Expense (Annual) : 3.056M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 3.056M |
| December 31, 2022 | 23.73M |
| December 31, 2021 | 22.90M |
| December 31, 2020 | 14.59M |
| December 31, 2019 | 25.84M |
| December 31, 2018 | 20.49M |
| December 31, 2017 | 16.40M |
| June 30, 2016 | 2.090M |
| June 30, 2015 | 4.568M |
| June 30, 2014 | 3.339M |
| June 30, 2013 | 1.912M |
| June 30, 2012 | 2.566M |
| June 30, 2011 | 3.720M |
| Date | Value |
|---|---|
| June 30, 2010 | 2.637M |
| June 30, 2009 | 2.354M |
| June 30, 2008 | 1.764M |
| June 30, 2007 | 1.208M |
| June 30, 2006 | 1.566M |
| June 30, 2005 | 1.417M |
| June 30, 2004 | 1.072M |
| June 30, 2003 | 0.8088M |
| June 30, 2002 | 0.3702M |
| June 30, 2001 | 0.4795M |
| June 30, 2000 | 0.4715M |
| June 30, 1999 | 0.1735M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Filana Therapeutics, Inc. | 26.59M |
| CorMedix, Inc. | 19.33M |
| Cannabis Global, Inc. | -- |
| Breakthrough Chemistry, Inc. | 0.0042M |
| BioStem Technologies, Inc. | 7.086M |